Fierce Virtual Series: JPM Week 2021 has ended

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Panel Discussions [clear filter]
Monday, January 11

10:00am EST

In-Development COVID-19 Therapeutics
What are the most promising therapeutics coming up through biopharma's pipelines? How can pharma improve on those therapeutics currently in use under emergency authorizations? What role will combinations play, and which mechanisms of action might pair well together? How many opportunities will be left for therapeutic makers after vaccines take hold? Which companies are looking to treat COVID's long-lasting effects (lung damage, kidney damage etc.) and how?

avatar for Amirah Al Idrus

Amirah Al Idrus

Editor, Fierce Biotech

avatar for Julie Kim

Julie Kim

President of the Plasma-Derived Therapies Business Unit, Takeda
Julie Kim is the President of the Plasma-Derived Therapies Business Unit for Takeda, responsible for building a sustainable, high growth business focused on meeting the large and growing demand for plasma-derived products, essential for effectively treating patients with a variety... Read More →
avatar for Levi Garraway, M.D., Ph.D.

Levi Garraway, M.D., Ph.D.

Chief Medical Officer, Roche and Genentech
Levi Garraway, M.D., Ph.D., was appointed Chief Medical Officer and Executive Vice President, Head of Global Product Development for Roche and Genentech in October 2019. He leads employees in the Product Development organization across the globe, oversees all aspects of late stage... Read More →
avatar for Ann Leen, Ph.D.

Ann Leen, Ph.D.

Chief Scientific Officer, AlloVir
Dr. Ann Leen is co-founder/CSO at AlloVir. She has seven+ years of industry experience and >20 years of basic and translational science experience in academia. She is based at the Center for Cell and Gene Therapy at Baylor where she serves as Professor, Pediatrics. She has developed... Read More →
avatar for Wendy Holman

Wendy Holman

CEO and Founder, Ridgeback Biotherapeutics
avatar for Karen Flynn

Karen Flynn

Chief Commercial Officer & President, Biologics, Catalent
Karen Flynn was named President, Biologics and Chief Commercial Officer in 2020. Prior to joining Catalent, she served as the Senior Vice President and Chief Commercial Officer of West Pharmaceutical Services, Inc. from 2016 to 2019, having previously served as that company’s President... Read More →

Monday January 11, 2021 10:00am - 10:45am EST
Tuesday, January 12

10:00am EST

"Second-Wave" COVID-19 Vaccines
avatar for Eric Sagonowksy

Eric Sagonowksy

Editor, Fierce Pharma
Eric Sagonowsky is an editor with the FierceMarkets Life Sciences team. Before joining Fierce in November 2014, Eric worked as a news reporter for the Manistee News Advocate in Manistee, Mich., covering government and crime issues. Eric graduated from Ohio University's E.W. Scripps... Read More →

avatar for Swati Gupta

Swati Gupta

Vice President and Head of Emerging Infectious Diseases and Scientific Strategy, IAVI
Swati Gupta, DrPH, MPH, leads IAVI’s Emerging Infectious Disease product portfolio and the development of the organization’s overall scientific strategy. She has a particular focus in leveraging IAVI’s recombinant vesicular stomatitis virus (rVSV) platform and expertise to expand... Read More →
avatar for Nathalie Landry

Nathalie Landry

Executive Vice President, Scientific and Medical Affairs, Medicago
Nathalie Landry is a dynamic biotech leader with more than 25 years of experience leading teams and programs to successful milestones. At Medicago, she oversees a multidisciplinary team in charge of research and development (R&D), product development, analytical development, process... Read More →
avatar for Thomas Lingelbach

Thomas Lingelbach

President and CEO, Valneva
Previous CEO of Intercell, Managing Director for Novartis Vaccines & Diagnostics Germany, Vice President of Global Industrial Operations at Chiron Vaccines, more than 25 years in the vaccine industry.  
avatar for Paul Stoffels, M.D.

Paul Stoffels, M.D.

Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson
Paul Stoffels is a visionary leader who inspires and drives transformational innovation to bring years of life and quality of life to millions of people around the world. Paul spearheads the Johnson & Johnson research and product pipeline by leading teams across all our sectors... Read More →
avatar for Ricci Whitlow

Ricci Whitlow

President, Clinical Supply Services, Catalent
Ricci Whitlow was named President, Clinical Supply Services in January 2020. She rejoins Catalent after two-and-a-half years, having previously held the position of VP Operations, overseeing nine manufacturing facilities across North and South America. Her most recent position was... Read More →

Tuesday January 12, 2021 10:00am - 10:50am EST
Wednesday, January 13

10:00am EST

The last mile: How will a COVID-19 vaccine make it from plant to patients?
Once a COVID-19 vaccine becomes available, it faces a number of logistic hurdles in making it to patients. Those hurdles include figuring out the best distribution channels, coming up with the most ethical and effective prioritization of distribution, convincing patients of its safety and, of course, figuring out who's going to pay for it all. We talk to the companies that are at the heart of making all this happen to better understand the challenges, questions and opportunities at play as the system prepares for the release of a COVID-19 vaccine.

avatar for Tina Reed

Tina Reed

Executive Editor, Fierce Healthcare
Tina Reed oversees Fierce Healthcare and all of its publications.  Tina has been reporting on healthcare for more than a decade and her work has appeared in Fierce Healthcare, the Washington Business Journal, the Capital Gazette, AnnArbor.com, The Ann Arbor News and the Las Vegas... Read More →

avatar for Chris Cox

Chris Cox

Senior Vice President of Pharmacy, CVS Health
Chris Cox is Senior Vice President of Pharmacy for CVS Health. He has been leading CVS Health's efforts to administer COVID-19 vaccines and serves as the company's liaison to Operation Warp Speed.  
avatar for J. Stephen Jones, MD

J. Stephen Jones, MD

President and CEO, Inova Health System
J. Stephen Jones, MD, is President and CEO of Inova, the Washington, DC region’s leading not-for-profit healthcare system serving more than 2 million people annually in its five hospitals and numerous ambulatory programs. He is also Professor of Urology at the University of Virginia... Read More →
avatar for Heather Zenk, RPh, PharmD

Heather Zenk, RPh, PharmD

SVP of Strategic Global Sourcing, AmerisourceBergen
Heather Zenk, RPh, PharmD, has responsibilities for developing and implementing traceability business processes and technology that will enhance patient safety, further secure the pharmaceutical supply chain and create broader service offerings to manufacturer partners and AmerisourceBergen... Read More →
avatar for Rick Gates

Rick Gates

Senior Vice President – Pharmacy and Healthcare, Walgreens
Rick Gates is senior vice president of pharmacy and healthcare at Walgreens, based in Deerfield Ill.  He is responsible for commercial development and sales, contracting, pharma development, pharmacy supply chain, and clinical programs and alliances.   Before then he was group... Read More →

Wednesday January 13, 2021 10:00am - 11:00am EST
  • Timezone
  • Filter By Date Fierce Virtual Series: JPM Week 2021 Jan 11 -13, 2021
  • Filter By Type
  • Interviews
  • Keynote
  • Networking
  • Panel Discussions
  • Presentations